Top

Netherlands Heart Journal

Gepubliceerd in:

01-06-2007 | debate article

Periodical cardiovascular screening is mandatory for elite athletes

Contra screening

Auteurs: S. W. Bredeweg, L. H. Takens, W. Nieuwland

Gepubliceerd in: Netherlands Heart Journal | Uitgave 6/2007

Abstract

In recent years sudden cardiac death (SCD) in sport has received more media attention. The death of a young competitive, sometimes well-known, athlete is a tragedy with great impact on lay and medical communities. The public and medical awareness of SCD will result in public, medical and political demands to introduce preventive measures to avoid SCD. In many countries it is being debated whether mandatory screening of athletes is the answer and some international sports bodies such as the IOC, FIFA, UEFA and ICU have already adopted screening procedures to fight SCD in sport.

vorige artikel Periodical cardiovascular screening is mandatory for elite athletes

volgende artikel Primary monophasic mediastinal, cardiac and pericardial synovial sarcoma: a young man in distress

Corrado D, Pelliccia A, Bjornstad HH. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden deaths: Proposal for a common European protocol. Eur Heart J 2005;26:516-24.

Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006;(16 Suppl 1):3-63.

Barratt A, Irwig L, Glasziou P, Cumming RG, Raffle A, Hicks N, et al. Users’ guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA 1999;281:2029-34.

Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac deaths during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32:1881-4.

Maron BJ. Sudden death in young athletes. N Engl J Med 2003; 349:1064-75.

Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.

Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.

Eckart RE, Scoville SL, Campbell CL, Virmani R. Sudden deathin young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 2004;141:829-34.

Maron BJ. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee and Congenital Cardiac Defects Committee, AHA. Circulation 1996;94:850-6.

Thompson PD, Levine BD. Protecting athletes from sudden cardiac death. JAMA 2006;296:1648-50.

Pelliccia A, Maron BJ, Culasso F, Di Paolo FM, Spataro A, Biffi A, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84.

Mitchell JH, Maron BJ. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Med Sci Sports Exerc 1994;26:223-83.

Wald DS, Law M, Morris JK. Mortality from hypertrophic cardiomyopathy in England and Wales: clinical and screening implications. Int J Cardiol 2004;97:479-84.

Logan S. Population screening for hypertrophic cardiomyopathy (HCM) - a review of the evidence. The National Screening Committee, United Kingdom 2003.

Titel: Periodical cardiovascular screening is mandatory for elite athletes
Contra screening
Auteurs: S. W. Bredeweg
L. H. Takens
W. Nieuwland
Publicatiedatum: 01-06-2007
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 6/2007
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/BF03085985

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2007

Periodical cardiovascular screening is mandatory for elite athletes

Primary monophasic mediastinal, cardiac and pericardial synovial sarcoma: a young man in distress

Diversity in cardiac sodium channel disease phenotype in transgenic mice carrying a single SCN5A mutation

Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics

Double aortic arch

ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy